A therapeutic agent for improving cerebral apoplexy comprising oiugenol or a derivative thereof as an active ingredient

摘要

The present invention relates to a therapeutic agent for ischemic stroke improvement comprising eugenol or a derivative thereof as an active ingredient. The pharmaceutical composition of the present invention can be administered in combination with an excipient such as a delay caused by excitatory amino acids NMDA (N-methyl-D-aspartate), AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionate) or Kainate Significant levels of hemicellular stroke can be prevented or treated as a cause of acute or neurotoxicity.